North America Biopreservation Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Biopreservation Market Size

• The North America Biopreservation Market was valued at USD 2.18 billion in 2024 and is expected to reach USD 3.45 billion by 2032 at a CAGR of 8.3% during the forecast period
• The increasing demand for regenerative medicine and personalized healthcare solutions, require the reliable preservation of biological samples such as cells, tissues, and organs. The growing use of stem cell therapies, gene editing, and cell-based treatments has significantly heightened the need for advanced biopreservation techniques.

North America Biopreservation Market Analysis

• Biopreservation plays a pivotal role in the management of vertebral compression fractures (VCFs), which are frequently linked to osteoporosis and aging. This technique supports critical outcomes such as pain relief, restoration of vertebral height, and improved patient mobility—collectively enhancing quality of life. Biopreservation solutions are widely utilized across hospitals, outpatient clinics, and rehabilitation centers, and are seeing growing use in home care settings for post-surgical recovery support.
• The demand for Biopreservation in North America is primarily driven by the increasing prevalence of osteoporosis-related fractures among the aging population. This trend is amplified by rising awareness of the clinical and economic benefits of minimally invasive interventions. Advances in medical technologies that improve surgical precision and reduce recovery times are accelerating the adoption of biopreservation across clinical settings. Additionally, the shift toward outpatient procedures and home-based recovery options is supporting broader market expansion.
• North America continues to hold a leading position in the North America Biopreservation market, backed by its robust healthcare infrastructure, high rate of technology adoption, and supportive reimbursement frameworks. The United States, in particular, dominates the regional market due to its high healthcare expenditure, large elderly population, and widespread integration of innovative surgical techniques that reduce inpatient stays and improve long-term patient outcomes.

Report Scope Biopreservation Market Segmentation 

Biopreservation Market Trends

“Minimally Invasive Innovations and Outpatient Procedure Growth”

• The market is witnessing a strong shift toward minimally invasive biopreservation procedures, driven by their ability to reduce surgical trauma, shorten recovery periods, and improve overall patient outcomes. Enhanced imaging systems and next-generation surgical tools are enabling greater procedural accuracy and efficiency, resulting in better spinal alignment and restoration in vertebral compression fracture (VCF) treatments.
• As procedures become faster and safer, there is a clear movement from inpatient settings to outpatient clinics and ambulatory surgical centers. This trend is fueled by cost-saving imperatives and improved procedural outcomes. With the support of advanced post-surgical care technologies and remote patient monitoring, healthcare providers are increasingly confident in managing recovery outside hospital walls—boosting accessibility and reducing system burden.

• For instance, the increasing focus on personalized medicine and regenerative therapies is driving a surge in demand for biopreservation solutions. As more emphasis is placed on preserving biological samples, such as cells, tissues, and organs, for research and therapeutic use, there is a growing need for advanced preservation technologies that ensure sample viability, improve recovery outcomes, and support the development of personalized treatment plans. This trend is particularly noticeable in stem cell therapies, tissue engineering, and biobanking sectors.

Biopreservation Market Dynamics

Driver

“Rising Prevalence of Osteoporotic Fractures and Increasing Geriatric Population”

• The North America Biopreservation Market is experiencing robust growth fueled by the increasing prevalence of osteoporosis-related vertebral compression fractures (VCFs), particularly among the aging population. As longevity rises, so does the demand for minimally invasive interventions that can address age-related spinal conditions effectively.
• The growing awareness of the benefits of minimally invasive procedures—such as quicker pain relief, restoration of spinal stability, and reduced hospital stays—is driving broader adoption of Biopreservation across both hospital and outpatient settings.
• With healthcare systems focusing on improving mobility and reducing long-term disability in older adults, Biopreservation is becoming a preferred approach due to its proven ability to restore vertebral height and function safely and effectively.

For instance,

• National Osteoporosis Foundation reports that approximately 1.5 million vertebral fractures occur annually in the U.S., with a large proportion linked to osteoporosis.
• In 2024, Medtronic launched a next-generation Biopreservation balloon catheter, offering improved navigation and enhanced bone access to facilitate safer, more effective fracture treatment.

Opportunity

“Technological Advancements and Expansion into Outpatient & Ambulatory Care Settings”

• A major opportunity in the Biopreservation market lies in the continuous innovation of procedural tools and materials, including advanced balloon technologies, integrated real-time imaging systems, and refined cement delivery techniques. These developments enhance surgical precision, safety, and procedural outcomes.
• The expansion of Biopreservation into outpatient clinics and ambulatory surgical centers (ASCs) presents a cost-effective alternative to hospital-based care. These settings provide improved accessibility, reduced overhead costs, and greater patient convenience.

For instance,

• For instance, in early 2024, Stryker introduced a streamlined Biopreservation system tailored for ambulatory surgery centers, reducing setup complexity and shortening procedure time.
• Collaborations between medical device companies and outpatient networks are also supporting workforce training and expanding access to Biopreservation beyond urban hospitals.

Restraint/Challenge

“High Procedure Cost and Reimbursement Barriers”

• One of the major challenges facing the North America Biopreservation Market is the high cost associated with the procedure. Expenses related to specialized equipment, real-time imaging, and post-operative care can limit patient access, especially among those lacking comprehensive insurance coverage.
• Inconsistent reimbursement policies across public and private insurers create uncertainty for healthcare providers and may deter smaller facilities from offering the procedure. Rural and underserved regions are particularly affected by these disparities.
• Furthermore, navigating the complex regulatory environment—which requires extensive clinical validation for new technologies—can delay product launches, increase development costs, and temporarily stifle innovation.

For instance,

• For instance, a 2023 CMS report noted variable reimbursement rates for vertebral augmentation procedures, contributing to inconsistent access across different U.S. states.
• Smaller clinics and healthcare providers often face financial hurdles in adopting Biopreservation systems due to low patient volumes and delayed reimbursement cycles.

Biopreservation Market Scope

The market is segmented on the basis, three notable segments based on By Product Type, application, End User .

In 2025, the Biopreservation Media is projected to dominate the market with a largest share in product type segment

The Biopreservation Media is expected to lead the North America Biopreservation Market in 2025. with the largest share of 46.62% in 2025 driven by its critical role in maintaining cell viability during storage and transport. Increasing use in stem cell, gene therapy, and biobanking applications is driving demand. Technological advancements in formulation and stability are further supporting market growth.

The Therapeutic Applications is expected to account for the largest share during the forecast period in application market

In 2025, Therapeutic Applications are projected to account for the largest share of the North America Biopreservation Market by application with the largest market share of 49.31% due to its growing use of preserved cells and tissues in regenerative medicine, stem cell therapy, and oncology treatments. Rising demand for personalized medicine further boosts the need for therapeutic biopreservation solutions.

Biopreservation Market Regional Analysis

“U.S. is the Dominant Country in the Biopreservation Market”

• The United States leads the North America Biopreservation Market, supported by a highly developed healthcare infrastructure, broad adoption of minimally invasive surgical technologies, and the strong presence of top-tier medical device manufacturers.
• The high incidence of osteoporosis-related vertebral compression fractures (VCFs), combined with a large and aging population, is fueling demand for effective, minimally invasive spinal procedures across hospitals and ambulatory surgical centers.
• Leading companies such as Medtronic, Stryker, and Globus Medical are deeply rooted in the U.S. market, offering advanced Biopreservation systems—including balloon-based kyphoplasty and precision cement delivery devices—that comply with regulatory standards and clinical performance requirements.
• Favorable reimbursement frameworks, increased physician training in minimally invasive techniques, and public health initiatives aimed at reducing long-term disability further cement the U.S.’s dominance in the regional Biopreservation landscape.

“Canada is Projected to Register the Highest Growth Rate”

• Canada is poised to experience the fastest growth in the North America Biopreservation Market, driven by rising government investment in bone health and expanded access to spinal care services targeting its aging population.
• The country’s publicly funded healthcare model and increasing awareness of minimally invasive alternatives for vertebral fracture management are accelerating the adoption of Biopreservation procedures across clinical settings.
• Growth in ambulatory surgical centers and rehabilitation clinics—especially in urban and semi-urban areas—is fueling demand for cost-effective, low-complication spinal treatments.
• National collaboration between health ministries, orthopedic associations, and academic institutions is fostering clinical education, technology adaptation, and domestic innovation in Biopreservation tools and techniques.

Biopreservation Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• Boston Scientific (U.S.)
• Philips Healthcare (Netherlands/U.S.)
• Stryker (U.S.)
• Globus Medical (U.S.)
• Zimmer Biomet (U.S.)
• Smith & Nephew (U.K.)
• Johnson & Johnson (U.S.)
• NuVasive (U.S.)
• CareFusion (U.S.)

Latest Developments in North America Biopreservation Market

• In March 2024, Merck Invests More than € 300 Million in New Life Science Production Site in Korea. This New Bioprocessing Production Center in Daejeon strengthened footprint of Merck in fast-growing Asia-Pacific region.
• In September 2023, Avantor Partnered with Tobin Scientific to Provide End-to-End Solution for Research Lab Relocations, Sample Transport, and GMP Storage Services to support end-to-end moves for U.S. biopharma customers looking to relocate their labs, research facilities, and samples. This partnership will deliver upon the growing customer need for complex logistics solutions with temperature-specific requirements. 

SKU-1210